Prescribing information available here

Patients switching to Easyhaler® are more likely to achieve overall disease control, have improved quality of life, and they are also more satisfied with their inhaler compared to their previous inhaler device.1,2 Patient satisfaction with their inhaler is associated with higher adherence and improved asthma control. 1–3





WehaleHCP_Insights_Syk et al 2019_Figure_700x394_20190502.png


Date of preparation: October 2022 / EASYH-2725



  1. Tamasi L, Szilasi M, Gálffy G. Clinical Effectiveness of Budesonide/Formoterol Fumarate Easyhaler®, for Patients with Poorly Controlled Obstructive Airway Disease: a Real-World Study of Patient-Reported Outcomes. Adv Ther. 2018;35:1140–1152.
  2. Gálffy G, Szilasi M, Tamási L. Effectiveness and patient satisfaction with budesonide/formoterol Easyhaler® among patients with asthma or COPD switching from previous treatment: a real-world study of patient-reported outcomes. Pulm Ther. 2019;5:165-177.
  3. Plaza V, Giner J, Calle M, Rytilä P, Campo C, Ribó P, Valero A. Impact of patient satisfaction with his or her inhaler on adherence and asthma control. Allergy Asthma Proc. 2018 Nov 18;39(6):437-444.
  4. Syk J, Vinge I, Sörberg M, Vahteristo M, Rytilä P. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler® to Budesonide/Formoterol Easyhaler®.Adv Ther 2019. [Epub ahead of print]